RxDoctor Payments Data

Elizabeth Thomas, DO

Transplant Surgery · San Antonio, TXNPI 1760663462

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (32.8%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 88.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $3,200 and has fallen 73.7% since, to $842 in 2025.

$4,570in general payments, 2019–2025

Across 25 payments — averaging $182.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$4K
  • Abbott$225
  • Abiomed$166
  • Johnson & Johnson$58
  • Organ Recovery Systems, Inc.$39
  • Baxter Healthcare$36
$715in research payments, 2019–2025

Across 2 payments — averaging $357.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Transmedics, Inc.$715

What the payments were for

  • Speaking & faculty fees$1,00022%
  • Travel & lodging$1,28828%
  • Food & beverage$78217%
  • Education$1,50033%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,570 in reported general payments places this provider in the 65th percentile of 70 transplant surgery providers in Texas.

See all transplant surgery providers in Texas

Medicare billing

Part B allowed, 2024
$96,800
Medicare patients
46
Services billed
101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Valganciclovir Hcl19$3,260
Easy Touch Pen NeedlePen Needle, Diabetic24$618
Nifedipine ErNifedipine14$143
Carvedilol22$113
Prednisone35$90
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim32$70
Rosuvastatin Calcium24$64
Pantoprazole Sodium21$47

Paid to pharmacies, not to this prescriber.

Other transplant surgery in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →